Published July 2013 | Version v1
Journal article

11C-Choline PET/CT and PSA kinetics

  • 1. Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola-Malpighi, UO di Medicina Nucleare, PAD. 30, Bologna (Italy)
  • 2. Policlinico S. Orsola-Malpighi, University of Bologna, Nuclear Medicine Unit, Bologna (Italy)
  • 3. National Research Council (IBFM-CNR), Nuclear Medicine Unit, San Raffaele Scientific Institute, Institute for Bioimaging and Molecular Physiology, Milan (Italy)

Description

The role of PET/CT with radiolabelled 18F-choline or 11C-choline in patients with prostate cancer after primary treatment has not been established yet and there are no guidelines on the appropriate use of this emerging modality. According to the literature, choline PET/CT may have a role in restaging the disease in patients with biochemical relapse for the detection of local and/or lymph node and/or distant recurrence. The aim of this brief review is to summarize the results of the most relevant published studies with particular focus on the relationship between prostate-specific antigen levels and kinetics and the sensitivity of choline PET/CT for optimizing the selection of patients who may benefit the most from this diagnostic procedure, especially early after biochemical recurrence. (orig.)

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00259-013-2377-z

Additional details

Identifiers

Publishing Information

Journal Title
European Journal of Nuclear Medicine and Molecular Imaging
Journal Volume
40
Journal Issue
Suppl.1
Series
Prostate Cancer
Journal Page Range
p. 36-40
ISSN
1619-7070